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Abstract
Background: Zinc oxide nanoparticles (ZnO NPs) are used in an increasing number of products, including rubber
manufacture, cosmetics, pigments, food additives, medicine, chemical fibers and electronics. However, the molecular
mechanisms underlying ZnO NP nephrotoxicity remain unclear. In this study, we evaluated the potential toxicity of
ZnO NPs in kidney cells in vitro and in vivo.
Results: We found that ZnO NPs were apparently engulfed by the HEK-293 human embryonic kidney cells and then
induced reactive oxygen species (ROS) generation. Furthermore, exposure to ZnO NPs led to a reduction in cell viability
and induction of apoptosis and autophagy. Interestingly, the ROS-induced hypoxia-inducible factor-1α (HIF-1α)
signaling pathway was significantly increased following ZnO NPs exposure. Additionally, connective tissue growth
factor (CTGF) and plasminogen activator inhibitor-1 (PAI-1), which are directly regulated by HIF-1 and are involved in
the pathogenesis of kidney diseases, displayed significantly increased levels following ZnO NPs exposure in HEK-293
cells. HIF-1α knockdown resulted in significantly decreased levels of autophagy and increased cytotoxicity. Therefore,
our results suggest that HIF-1α may have a protective role in adaptation to the toxicity of ZnO NPs in kidney cells. In an
animal study, fluorescent ZnO NPs were clearly observed in the liver, lungs, kidneys, spleen and heart. ZnO NPs caused
histopathological lesions in the kidney and increase in serum creatinine and blood urea nitrogen (BUN) which indicate
possible renal possible damage. Moreover, ZnO NPs enhanced the HIF-1α signaling pathway, apoptosis and autophagy
in mouse kidney tissues.
Conclusions: ZnO NPs may cause nephrotoxicity, and the results demonstrate the importance of considering the
toxicological hazards of ZnO NP production and application, especially for medicinal use.
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Background
Hypoxia-inducible factor-1 (HIF-1) is a transcription fac-
tor that mediates adaptive responses to hypoxia at both
the cellular and systemic levels [1]. HIF-1 is a heterodi-
mer composed of the HIF-1α and HIF-1β subunit. It is
regulated primarily through oxygen-dependent changes
in the stability of the α subunit [2]. Hypoxic stimuli
increase HIF-1α protein by inhibiting its degradation by
the proteasome [3]. HIF-1 has been shown to regulate
the expression of hundreds of target genes involved in
angiogenesis, erythropoiesis, metabolism, apoptosis, au-
tophagy, and other adaptive responses to hypoxia [4, 5].
Previous studies have demonstrated that reactive oxygen
species (ROS) are involved in the oxygen-sensing mech-
anism. The exogenous application of H2O2 can induce
HIF-1α under normoxic conditions and ROS scavengers
can block hypoxic induction of HIF-1 [6]. In addition,
HIF-1 is involved in the regulation of many biological
processes that are related to kidney function under
physiological and pathological conditions. In fully
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developed kidneys, HIF-1α is expressed in most cell types
[7]. Factors that are directly regulated by HIF and are in-
volved in the pathogenesis of acute and chronic kidney
diseases include heme oxygenase-1 (HO-1), vascular
endothelial growth factor (VEGF), plasminogen activator
inhibitor-1 (PAI-1), tissue inhibitor of metalloproteinase-1
(TIMP-1), connective tissue growth factor (CTGF),
erythropoietin, Wilms’ tumor suppressor (WT-1), and
others [8]. An increase in HIF-1α in human and rat dis-
eases, including polycystic kidneys and polycystic livers,
has been reported [9, 10].
Zinc oxide nanoparticles (ZnO NPs) have become in-
creasingly common in electronics, catalysts, clothing,
paints and sunscreens [11, 12]. Current interest in ZnO
NPs is focused on their medicinal use and biological ap-
plications, including as a biosensor and for drug delivery
[13]. However, these applications increase human and
environmental exposure and the potential risk for tox-
icity [14]. NPs can enter the human body via different
routes such as inhalation, ingestion and injection [15].
They can then translocate to the blood, causing adverse
biological reactions in several organs. To increase the
potential of nanomedicine in ZnO NPs, full attention is
needed to safety and toxicological issues. Because injec-
tion of ZnO NPs are brought intentionally into the hu-
man body, the concentration of ZnO NPs is higher than
inhalation and ingestion in environment [16]. Further-
more, the kidney is particularly susceptible to xenobi-
otics because of its high blood supply and its ability to
concentrate toxins [17, 18]. ZnO NPs significantly de-
creased the total renal total glutathione level compared
with control values, which indicates functional damage
to kidney tissues [18]. Another recent study concluded
that ZnO NPs can disturb energy metabolism and impair
mitochondria and cell membrane in rat kidneys [19].
Huang et al. indicated that titanium NP inhalation might
induce renal fibrosis through a ROS/reactive nitrogen
species- mediated HIF-1α-upregulated TGF-β signaling
pathway [20]. Therefore, ZnO NPs may induce nephro-
toxicity. However, the underlying molecular mechanisms
are unclear.
Autophagy is a tightly regulated intracellular bulk deg-
radation and recycling system that plays important roles
in cellular homeostasis [21]. Previous studies have dem-
onstrated that upregulation of autophagy in the kidney
proximal tubules was observed in several experimental
acute kidney injury (AKI) models [22, 23]. Ischemia-
reperfusion (I/R) injury increased predominantly the
number of autophagic vesicles in proximal tubules [24].
Other groups have shown that autophagy is protective
against cisplatin-induced AKI [25, 26]. Autophagy is es-
sential for scavenging damaged organs in cells. There-
fore, autophagy plays a protective role during kidney
disease [21]. In addition, autophagy has been described
as a HIF-1α-dependent adaptive response [27]. In some
disease models, HIF signaling results in increased levels
of a BH3-only protein—Bcl-2/E1B 19 kDa-interacting
protein 3 (BNIP3), a protein that protects against cell
death during activation of autophagy [28]. However,
there are few published articles describing the relation-
ship between autophagy and ZnO NPs [29, 30]. Collect-
ively, the previously described reports demonstrate that
exposure to ZnO NPs may affect renal cells. The object-
ive of the present study was to investigate the effect of
ZnO NPs on autophagy and apoptosis in kidney cells in
vitro and in vivo. Furthermore, we examined the inter-
play between autophagy and HIF-1α in kidney cells ex-
posed to ZnO NPs.
Methods
Cell culture and co-incubation with ZnO NPs
The human embryonic kidney cell line HEK-293 (ATCC
CRL-1573) was obtained from the American Type Culture
Collection (ATCC). Cells were maintained under standard
growth conditions in a humidified incubator in Eagle’s
minimum essential medium (MEM), 10 % fetal bovine
serum, 100 U/ml penicillin, 100 μg/ml streptomycin
0.1 mM non-essential amino acids and 1.0 mM sodium
pyruvate (Gibco BRL, Grand Island, NY) at 37 °C and 5 %
CO2. Exponentially growing cells were detached with
0.05 % trypsin-EDTA (Gibco BRL, Grand Island, NY) in
MEM medium. ZnO NP solutions were freshly prepared
from stock solutions and sonicated for 5 min before
addition to cell cultures.
Preparation and physicochemical characterization of
ZnO NPs
First, ZnO NPs were obtained by as previously reported
[31]. Zinc acetate dihydrate (Zn(CH3COO)2(H2O)2;
147 mg) was dissolved in 6.25 ml of methanol and a po-
tassium hydroxide (KOH) solution was prepared by dis-
solving 74 mg of KOH in 3.25 ml of methanol. Then,
the KOH solution was added dropwise into the zinc
acetate solution with vigorous stirring after heating the
zinc acetate solution to 60 °C. After 1.5 h, the solution
become turbid and precipitates were slowly produced after
the solution was allowed to stand at room temperature for
another 2 h. The precipitates (ZnO NPs) were collected
by centrifugation at 10,000 rpm for 10 min and were
washed twice with methanol. The precipitates were dis-
persed in 10 ml ethanol. Then, 50 μL of (3-aminopropyl)
triethoxysilane (APTES), 100 μl of deionized water, and
10 μl of 25 % wt ammonia aqueous solution were added
to the ZnO NP solution. The mixed solution was stirred
at room temperature for 20 h. The solution was centri-
fuged at 10,000 rpm for 15 min, and the supernatant was
discarded. The precipitates (NH2-ZnO@SiO2 NPs) were
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washed twice with ethanol and re-dispersed in ethanol or
deionized water for further use.
The average hydrodynamic size and polydispersity index
(PDI) of the ZnO NPs were determined by dynamic laser
scattering (Delsa™ Nano C, Beckman Coulter, Inc., USA).
This instrument is capable of measuring particles ranging
from 0.6 nm to 7 μm. The zeta potential of the ZnO NPs
was measured by the Zetasizer Nano ZS90 (Malvern
Instruments Ltd,, UK). The size measurements were per-
formed on dilute ZnO NP suspensions in aqueous solu-
tion and MEM (including 10 % FBS). Characterization of
the ZnO NPs was performed using transmission electron
microscopy (TEM) (JEOL Co., MA, USA). ZnO NPs were
examined after suspension in aqueous solution and subse-
quent deposition onto copper-coated carbon grids.
Zinc release from the particle suspension was measured
by ICP-AES (Jobin Yvon JY138 spectroanalyzer, Horiba
Jobin Yvon, Inc., USA). Samples were prepared by diluting
the stock particle suspension in complete culture medium
at a concentration of 20 μg/ml ZnO NPs for 24 h. After
incubation, aliquots of the particle suspensions were cen-
trifuged. Then, the samples were microwave digested in
reverse aqua regia (1:3 HCl:HNO3) and zinc concentration
was analyzed by ICP-AES. Results were expressed as the
percentage of the tested suspension.
Cell viability assay
The cellular viability was assessed by the MTS assay,
which measures at the reduction of (3-(4,5-dimethyl-
thiazol-2-yl)- 5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium (MTS) to formazan in viable cells.
Briefly, cells were plated onto 96-well plates (Thermo,
MA, USA). After incubation with the indicated dose of
ZnO NPs for various lengths of time at 37 °C, formazan
absorbance was measured at 490 nm. The mean absorb-
ance of non-exposed cells was the reference value for cal-
culating 100 % cellular viability.
ZnO NP uptake using fluorescence confocal microscopy
and flow cytometry
We plated cells onto 6-well plates with a glass coverslip
per well. After ZnO NP exposure, cells were fixed with
4 % paraformaldehyde. After three washes in PBS, the
cells were stained with 4′-6-diamidino-2-phenylindole
(DAPI) (Sigma, MO, USA). Fluorescence confocal im-
ages were taken using a confocal microscope (Carl Zeiss
LSM 780, Instrument Development Center, NCKU). The
uptake of particles into cells was also analyzed by flow
cytometry (Becton Dickinson, USA). The side scatter
(SSC) data were analyzed using CELLQuest™ software
(Becton Dickinson). Ten thousand cells were acquired
for each measurement.
ROS production measurement
To measure ROS generation, a fluorometric assay was
carried out using the intracellular oxidation of 2,7-
dichlorofluorescein diacetate (DCFH-DA, Sigma, MO,
USA). The cells were treated with different concentrations
of the ZnO NPs for 2, 4 or 6 h and were then incubated
with 10 μM DCFH-DA for 30 min. After washing with
PBS, DCFH fluorescence of the cells from each well was
measured in a fluorescence microplate reader (Thermo,
MA, USA) at an excitation wavelength of 485 nm and
emission at 530 nm. The intensity of fluorescence reflects
the extent of oxidative stress.
Annexin V and propidium iodide (PI) staining assay
Cells were trypsinized, washed with PBS and centrifuged
at 2000 rpm for 5 min. Cells were resuspended in 100 μl
of 1 × Annexin V binding buffer (10 mM HEPES
(pH 7.4), 0.14 M NaCl and 2.5 mM CaCl2) that con-
tained 2 μl of Annexin V-FITC (Calbiochem, CA, USA)
alone or in combination with 10 μl of PI (50 μg/ml) and
were incubated in the dark at room temperature for
15 min. The 1× binding buffer (400 μl) was added to
stop the reaction, and staining was analyzed by FACScan
flow cytometry (Becton Dickinson, USA).
Cell staining with acridine orange for detection of
autophagy
Cell staining with acridine orange (AO) (Sigma Chemical
Co., USA) was performed according to published proce-
dures [32].
Immunofluorescence microscopy
The cells were cultured on coverslips. After ZnO NP treat-
ment, the cells were fixed in 4 % paraformaldehyde and
blocked with 1 % BSA for 30 min. This was followed by in-
cubation with a specific antibody against microtubule-
associated protein light chain 3 (LC3) (MBL, Japan) for
1 h. After washing, the cells were labeled with a DyLight™
488-conjugated AffiniPure goat anti-rabbit IgG (Jackson
ImmunoResearch Laboratories, PA, USA) for 1 h and
stained with DAPI. Finally, the cells were washed in PBS,
coverslipped, and examined with a fluorescence micro-
scope or confocal microscope (Carl Zeiss LSM780, Instru-
ment Development Center, NCKU).
Western blot analysis
Total cellular protein lysates were prepared by harvest-
ing cells in protein extraction buffer for 1 h at 4 °C as
described previously [32]. GAPDH was used as the pro-
tein loading control. Anti-PAI-1, anti-Bax and anti-
Beclin 1 were obtained from Cell Signaling Technology
(Ipswich, MA, USA); anti-HIF-1α was obtained from BD
Transduction Laboratories (San Diego, CA, USA); anti-
GAPDH was obtained from Abcam (Cambridge, MA,
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USA); anti-LC3 and anti-CTGF were obtained from
Abgent (San Diego, CA, USA); anti-p62/SQSTM1 was
obtained from MBL (Nagoya, Japan); anti-pro-caspase 3
and anti-cleaved-caspase 3 were obtained from Epitomics
(Burlingame, CA, USA).
RNA interference (RNAi)
We used Arrest-In Transfection Reagent (Thermo, MA,
USA) to transfect cells according to the manufacturer’s
protocol. HIF-1α siRNA (ID: s6541) was obtained from
ThermoFisher Scientific (Waltham, MA, USA).
Biodistribution
First, to prepare red-NIR700-ZnO NPs, fluorescent red-
NIR700 (purchased from Sigma-Aldrich, 61059, λex
672 nm; λem ~735 nm) was used because red-NIR700
has an N-hydroxysuccinimide (NHS) group and can
form a covalent bond with a primary amine. of R6G-
isothiocyanates (0.2 ml of 0.01 mM) and NH2-ZnO@-
SiO2 NPs (2 ml of 200 μg/ml) were mixed together and
stirred at room temperature for 4 h. Red-NIR700-
ZnO@SiO2 NPs were collected by centrifugation at
10,000 rpm for 15 min, and the supernatant was re-
moved. The isolated products were washed twice with
ethanol and re-dispersed in deionized water.
All experiments using mice were performed according to
the guidelines of our institutes (the Guide for Care and Use
of Laboratory Animals, National Cheng Kung University
and Taipei Medical University). Female BALB/c mice
(8 weeks old) were acquired from the animal center of the
National Cheng Kung University Medical College. The ani-
mals were housed 5 per cage at 24 ± 2 °C with 50 ± 10 %
relative humidity and subjected to a 12-h light/12-h dark
cycle. BALB/c mice were i.p. injected with red-NIR700-
ZnO NPs (a dose of 10 mg/kg) and then were sacrificed at
6 h after injection. Various organs were collected, and fluor-
escence imaging was conducted using an IVIS 200 imaging
system coupled to a data acquisition computer run-
ning Living Image Software (Xenogen).
In vivo experiment protocol
Female BALB/c mice (8 weeks old) were acquired from
the BioLASCO Experimental Animal Center (Taiwan).
The animals were housed 5 per cage at 24 ± 2 °C with
50 ± 10 % relative humidity and subjected to a 12-h
light/12-h dark cycle. The animals were acclimatized for
1 week prior to the start of the experiments. Mice were
fed a Purina chow diet with water ad libitum. Mice were
randomly divided into four groups (5 animals/group):
ZnO NPs once per week for four weeks. Varying con-
centrations of ZnO NPs were suspended in MQ water.
ZnO NP solutions were freshly prepared from stock so-
lutions and sonicated for 5 min before intraperitoneal
(i.p.) or intravenous (i.v.) injection. Mice were sacrificed
via CO2 exposure. After euthanasia, the kidney tissues of
mice were formalin-fixed and paraffin-embedded for
immunohistochemistry.
Inductively coupled plasma atomic emission spectroscopy
(ICP-AES)
To evaluate zinc levels in the different tissues, samples
from the lung, liver, kidney, spleen and heart were ob-
tained and weighed. The samples were microwave
digested in reverse aqua regia (1:3 HCl:HNO3) and ana-
lyzed for zinc concentrations by ICP-AES (Jobin Yvon
JY138 spectroanalyzer, Horiba Jobin Yvon, Inc., USA).
Biochemical tests
Whole blood samples from treated mice were collected
by intracardiac puncture and centrifuged at 2000 × g for
20 min to separate the serum. Biochemical evaluations
included glutamate oxaloacetate transaminase (GOT) ac-
tivity, glutamate pyruvate transaminase (GPT) activity,
blood urea nitrogen (BUN) levels and creatinine levels.
The urinary creatinine concentrations were detected by
Parameter Creatinine assay kit (R&D Systems, MN,
USA). Creatinine clearance (CCr) was calculated by the
standard formula CCr = (U × V)/S, where U is the cre-
atinine concentration in urine (mg/dL), V is urine flow
rate (μl/min), and S is the creatinine concentration in
serum (mg/dL).
Histopathological and immunohistochemical (IHC)
staining analysis
Paraffin-embedded tissue sections (2 μm) were dried,
deparaffinized, and rehydrated. Following microwave
pretreatment in citrate buffer (pH 6.0; for antigen re-
trieval), the slides were immersed in 3 % hydrogen per-
oxide for 20 min to block the activity of endogenous
peroxidase. The histopathological observations were
interpreted by staining tissue sections with hematoxylin
and eosin. Tissue sections were immunohistochemically
incubated overnight at 4 °C with the anti-LC3 (MBL,
Japan), anti-HIF-1α (BD Transduction Laboratories,
USA) or anti-cleaved-caspase 3 (Epitomics, USA) anti-
bodies. The sections were then incubated with a second-
ary antibody for 1 h at room temperature, and the slides
were developed using the STARR TREK Universal HRP
detection kit (Biocare Medical, Concord, CA). Finally,
the slides were counterstained using hematoxylin.
Statistical analysis
Data are expressed as the mean ± SD. Statistical signifi-
cance was determined using Student’s t-test for compari-
son between the means or one-way analysis of variance
with a post-hoc Dunnett’s test. Differences were consid-
ered significant when p <0.05.
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Results
ZnO NP characterization
To assess the physical characteristics of ZnO NPs, sev-
eral parameters were measured. The detailed results of
the physical characterization after suspension in cell cul-
ture medium or water are presented in Table 1. ZnO
NPs had a hydrodynamic diameter of 47.8 nm in water
and 70.5 nm in MEM. The zeta potential of ZnO NPs in
water was positive (+36.7), which ZnO NPs in MEM had
negative charges (−8.09). As previously reported, all of
the NPs have negatively charged surfaces in cell culture
medium due to the formation of a corona of negatively
charged proteins [33]. The polydispersity index (PDI) in-
dicates the dispersion stability and solubility of NPs in
water or medium, and a PDI value lower than 0.2 is as-
sociated with a high homogeneity of the particle
Table 1 Physical characteristics of ZnO NPs
Hydrodynamic diameter (nm) PDIa Zeta potential (mV) Dissolution (μg/ml)b
Water MEM Water MEM Water MEM Water MEM
ZnO 47.8 70.5 0.128 0.230 +36.7 −8.09 0.12 0.18
aPDI is the polydispersity index






Fig. 1 Cellular uptake and cytotoxicity of ZnO NPs by HEK-293 cells. a TEM analysis of ZnO NP morphology. ZnO NPs were mainly spherical in
shape. The scale bar represents 100 nm. b Cell viability was measured using the MTS assay. ZnO NPs decreased the viability of HEK-293 cells in a
concentration-dependent manner. The cells were treated with 0, 15, 20, 25, 30 or 35 μg/ml ZnO NPs for 24 h. All of the MTS values were normalized to
the control values (no particle exposure), which were regarded as 100 % cell viability. *p < 0.05 versus control. c Uptake of ZnO NPs detected by fluor-
escence confocal microscopy. ZnO NPs are shown in red and DAPI (blue) is a nuclei-specific marker. The cells were treated with 20 μg/ml ZnO NPs for
8 h. d, The results of the SSC data and flow cytometry demonstrated that ZnO NPs were apparently engulfed by HEK-293 cells. e Quantification of the
scatter intensity in HEK-293 cells with ZnO NP treatment. The cells were treated with ZnO NPs at 0, 15, 20, or 25 μg/ml for 24 h. The data are presented
as the mean ± standard deviation of three independent experiments
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population [34]. The values for ZnO NPs in water and
MEM were 0.128 and 0.230, respectively. Furthermore,
dissolution of NPs is an important property that influ-
ences their mode of action (e.g. antimicrobial properties,
toxicity, medicinal applications and environmental im-
pact) [35]. In our case, the release of zinc ions after 24 h
of incubation was low, <1 % of the initial concentrations
for ZnO NPs in water and MEM. In addition, the TEM
image suggests that the particles are polydispersed and
are mostly spherical in shape (Fig. 1a).
Cytotoxic effects, cellular uptake and the HIF-1α signaling
pathway in HEK-293 cells treated with ZnO NPs
To assess the cytotoxic effects of ZnO NPs in kidney
cells, we used the MTS assay (Fig. 1b). Our results dem-
onstrated that ZnO NPs reduced the viability of HEK-
293 cells in a concentration-dependent manner. Next, to
evaluate the entry of the ZnO NPs into the cells, we
used fluorescent ZnO NPs (Fig. 1c). Confocal micros-
copy analysis showed that exposure to ZnO NPs in-
creased the fluorescence intensity of HEK-293 cells. The
side scatter (SSC) intensity analyzed by flow cytometry
also confirmed that the ZnO NPs were apparently
engulfed by the HEK-293 cells in a concentration-
dependent manner (Figs. 1d-f ).
ZnO NPs may cause oxidative stress resulting in lipid
peroxidation, cell membrane damage and, ultimately,
cell death or apoptosis in macrophages and human cells
[36]. We determined the intracellular ROS level by
DCFH-DA (Fig. 2a). The results showed that ZnO NPs
stimulated ROS formation in cells in a concentration-
dependent manner. It has been reported that ROS in-
duce HIF-1α activation [37]. HIF-1α is involved in the
pathogenesis of kidney diseases, as are PAI-1 and
CTGF [8]. As shown in Fig. 2b, the expression of HIF-
1α, PAI-1 and CTGF significantly increased following
ZnO NP exposure.
Measurement of apoptosis and autophagy in HEK-293
cells treated with ZnO NPs
Apoptosis in HEK-293 cells was measured by flow cy-
tometry following Annexin V and PI staining (Fig. 3a
and b). We observed a substantial increase in percent-
age of apoptotic cells following treatment with ZnO
NPs. The expression of apoptosis-related proteins
(cleaved-caspase 3 and Bax) was examined by western
blotting analysis (Fig. 3c). The cleaved-caspase 3 and
Bax protein levels increased following ZnO NP treat-
ment compared with the control. Furthermore, we ana-
lyzed the type II programmed cell death, autophagy,
which is characterized by the presence of acidic vesicular
organelles (AVOs) in the cell cytoplasm. AVO formation
was detected and measured by vital staining with acridine
orange (AO) [38]. We found a significantly increased
amount of AO-positive cells in the ZnO NP treatment
group compared to the control (Fig. 4a and b). We de-
tected autophagosomes in ZnO NP-treated cells using a
green fluorescence-labeled LC3 immunofluorescence
assay (Fig. 4c). The results showed that the number of
vacuoles (green dots inside cells) increased conspicu-
ously. Meanwhile, we observed increased expression of
the autophagy-related proteins LC3-II, Beclin 1 and
p62 following ZnO NP treatment (Fig. 4d). Next, we
performed TEM analysis to analyze the ultrastructures
of the HEK-293 cells treated with ZnO NPs (Fig. 4e). In
the cytoplasm of the cells treated with ZnO NPs, we
observed a large number of autophagic vacuoles.
The HIF-1α signaling pathway is involved in the ZnO
NP-induced autophagy in HEK-293 cells
To further define the role of HIF-1α, we silenced HIF-1α
expression using HIF-1α siRNA in HEK-293 cells. The
expression of the HIF-1α proteins was markedly de-
creased in the cells treated with the HIF-1α siRNA com-
pared with the control siRNA (Fig. 5a). The viability of
the cells after siRNA transfection and ZnO NP treat-
ment was determined by MTS assays. As shown in
Fig. 5b, transfection with HIF-1α siRNA significantly
A
B
Fig. 2 Effects of ZnO NPs on cellular ROS and the expression of
HIF-1α-related proteins in HEK-293 cells. a ROS generation in HEK-293
cells treated with ZnO NPs for 1, 3 or 5 h and with DCFH-DA for an
additional 30 min. The fluorescence in the cells was immediately ana-
lyzed using a fluorescence microplate reader. b Western blotting for
HIF-1α, PAI-1 and CTGF in HEK-293 cells. The cells were treated with
ZnO NPs for 24 h
Lin et al. Particle and Fibre Toxicology  (2016) 13:52 Page 6 of 14
enhanced the cytotoxicity of ZnO NPs in HEK-293 cells.
Furthermore, we used HIF-1α siRNA to determine
whether inhibition of HIF-1α alters ZnO NP treatment-
induced apoptosis and autophagy. The results indicated
that ZnO NP treatment with HIF-1α siRNA let to a sig-
nificant decrease in autophagic cells compared to ZnO
NPs alone (Fig. 5d). However, HIF-1α siRNA alone
showed no noticeable change in apoptotic cells (Fig. 5c).
These results suggest that HIF-1α-knockdown enhances
the ZnO NP-induced cytotoxicity and suppresses the
ZnO NP-induced autophagy.
In vivo biodistribution and nephrotoxicity in ZnO
NP-treated mice
In vivo biodistribution of ZnO NPs can provide essen-
tial information on ZnO NP behavior post administra-
tion. We mimicked the medicinal use of ZnO NPs and
thus used i.p. or i.v. injection for administration of ZnO
NPs. To achieve this aim with high sensitivity, red-
NIR700, a commonly used NIR fluorescent dye, was used
with ZnO NPs to elucidate ZnO NP biodistribution in
vivo. BALB/c mice were i.p. injected with red-NIR700-
labeled ZnO NPs (at a dose of 10 mg/kg) and then sacri-
ficed after 6 h. Our results showed that ZnO NPs can ac-
cumulate in the liver, lungs, kidneys, spleen and heart
(Fig. 6a). In addition, the concentrations of Zn were evalu-
ated using an ICP-AES (Fig. 6b). The Zn concentration in
the lung, kidney, liver, spleen and heart showed a signifi-
cant increase in comparison with the control groups. To
further investigate the nephrotoxicity of ZnO NPs, the
mice were i.p. or i.v. injected with varying concentrations
of ZnO NPs. For the serum biochemical analysis, the ac-
tivities of GOT, GPT, creatinine and BUN were signifi-
cantly increased in the ZnO NP-treated mouse groups
(Table 2 and Additional file 1: Table S1). ZnO NP treat-
ments also decreased CCr levels (Additional file 1: Figure
S1). Furthermore, the kidneys were sliced and stained with
H&E. The histopathological lesions of the kidneys showed
tubular dilatation, loss of brush borders and flattening of
tubular epithelium, reduced Bowman’s space and in-
creased cellularity in the glomeruli of ZnO NP-treated




Fig. 3 Measurement of apoptosis in HEK-293 cells treated with ZnO NPs. a Annexin V/PI staining in HEK-293 cells treated with ZnO NPs. The in-
duction of apoptosis and necrosis was determined by flow cytometric analysis of Annexin V and PI staining. b Quantification of apoptotic cells
with Annexin V-stained cells using flow cytometry. HEK-293 cells treated with different concentrations of ZnO NPs were assessed using Annexin
V/PI staining. Cells were incubated with 0–25 μg/ml ZnO NPs for 24 h. *p < 0.05 versus control. The data are presented as the mean ± standard
deviation of three independent experiments. c Western blotting for procaspase-3, cleaved-caspase-3 and Bax in HEK-293 cells. Cells were treated
with 0–25 μg/ml ZnO NPs for 24 h
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Next, HIF-1α, LC3 and cleaved-caspase-3 expression
levels were examined in the kidney tissue using IHC
staining (Fig. 7a-c). Significant increases in kidney ex-
pression of HIF-1α, LC3 and cleaved-caspase-3 were ob-
served in the ZnO NP treatment group compared with
the control group. In addition, proteins extracted from
the kidney tissues were assayed by western blotting
(Fig. 7d). We found that HIF-1α, CTGF, LC3-II and
cleaved-caspase-3 protein levels were increased in the
ZnO NP treatment group. Thus, ZnO NPs could cause
renal histopathological lesions and regulate the HIF-1α
signaling pathway in the kidney.
Discussion
Many studies have examined the side effects of NPs, es-





Fig. 4 Measurement of autophagy in HEK-293 cells treated with ZnO NPs. a Development of AVOs in HEK-293 cells. Detection of green and red
fluorescence in AO-stained cells using flow cytometry. b Quantification of AVOs treated with ZnO NPs with AO. Cells were incubated with 0–25 μg/ml
ZnO NPs for 24 h. *p < 0.05 versus control. The data are presented as the mean ± standard deviation of three independent experiments.
c Immunofluorescence staining of the LC3 protein in HEK-293 cells treated with 20 μg/ml ZnO NPs for 24 h. d Western blotting for LC3-I, LC3-II, Beclin
1 and p62 in HEK-293 cells. Cells were treated with 0–25 μg/ml ZnO NPs for 24 h. e Ultrastructural changes observed in HEK-293 cells after ZnO NP
treatment. Cells were treated with medium alone (untreated) or 20 μg/ml ZnO NPs for 24 h. The white arrowheads indicate the autophagic vacuoles
and autolysosomes. N, nucleus
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published articles describing the relationship between
ZnO NPs and nephrotoxicity. Beckett et al. indicated
that inhalation of ZnO fumes at relatively high dose
(500 μg/m3) for 2 h in an occupational setting can cause
metal fume fever (fatigue, chills, fever, myalgias, cough,
dyspnea, leukocytosis, metallic taste and salivation) [39].
In healthy skin, the epidermis provides excellent protec-
tion against ZnO NPs spread to the dermis [40]. How-
ever, few human health studies are available on ZnO
exposure. Previous research has shown that ZnO NPs
can cause hepatic injury in mouse model [41]. In the
present study, significant increases in GOT and GPT
were found in all mice exposed to ZnO NPs (Table 2
and Additional file 1: Table S1). It is likely that renal ex-
posure to NPs would be commensurate with the organ’s
key role in the excretion of xenobiotics. The results from
this study demonstrated that ZnO NPs had a severe
renal toxicological effect and increased of blood bio-
chemical markers (BUN and creatinine) which indicate
possible renal damage (Fig. 6c, Additional file 1: Figure
S2, Table 2 and Additional file 1: Table S1). ZnO NPs
have been shown to induce cyto- and genotoxicity in
kidney epithelial cells [42]. Our in vitro studies revealed
that ZnO NPs were cytotoxic to the human kidney cell
line HEK-293, possibly due to ROS generation (Figs. 1b
and 2a). Furthermore, the uptake of NPs by cells is an
important factor in their toxicity. Inhibition of cellular
uptake of ZnO NPs would largely reduce the cytotoxicity
[43]. The results of the present study indicated that ZnO
NPs entered into cells in a concentration-dependent
manner (Fig. 1c-f). In addition, ZnO NPs increased
apoptosis in HEK-293 cells and in the kidneys of a
mouse model (Figs. 3 and 7). The cellular uptake ROS
generation and apoptosis may be the intrinsic reasons
for the high toxicity of ZnO NPs. Previous studies have
demonstrated that fluorescence labeling NPs had a small
but significant reduction in the level of cytotoxicity and
led to a minor increase in particle aggregation when
compared against the non-labeled particles. A possible




Fig. 5 HIF-1α knockdown by siRNA affects the cytotoxicity and autophagy of HEK-293 cells. a Transfection efficacy was verified by western blot
analysis. HIF-1α protein expression in HEK-293 cells transfected with control or HIF-1α siRNA for 24 h. b Cell viability in the absence or presence of
HIF-1α siRNA in HEK-293 cells. c Quantification of apoptotic cells with Annexin V-stained cells using flow cytometry. d Quantification of AVOs with
AO-stained cells transfected with control or HIF-1α siRNA using flow cytometry. The cells were transfected with control or HIF-1α siRNA for 24 h
and treated with medium alone or 20 μg/ml ZnO NPs for 24 h. *p < 0.05, control siRNA + ZnO NPs versus HIF-1α siRNA + ZnO NPs
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Fig. 6 In vivo biodistribution of ZnO NPs and histopathological analysis of kidneys after i.p. injection of ZnO NPs. a The images of liver, lungs,
kidneys, spleen and heart under NIR illumination clearly demonstrate the presence of ZnO NPs in these organs. BALB/c mice were i.p. injected
with red-NIR700-ZnO NPs (a dose of 10 mg/kg) and were sacrificed 6 h after injection. Various organs were collected, and fluorescence imaging
was conducted using an IVIS 200 imaging system. b Concentration of ZnO NPs in tissues. The mice were i.p. injected with ZnO NPs (a dose of
10 mg/kg) and were sacrificed 6 h after injection. The concentrations of Zn in the lung, kidney, liver, spleen and heart were evaluated using an
ICP-AES. *p < 0.05 versus control. c Histopathological kidney lesions were found in ZnO NP-treated mice. Tissue sections were stained with H&E
and observed microscopically. The black arrows indicate tubular dilatation. The black arrowheads indicate the loss of brush borders and flattened
tubular epithelium. The asterisks indicate the reduction of Bowman’s space and the increase in cellularity in glomeruli. BS, bowman space;
G, glomerulus
Table 2 Biochemical tests including BUN, creatinine, GOT and GPT after i.p. injection of ZnO NPs
Item/Group 0 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg
BUN (mg/dL) 18.76 ± 3.75 23.46 ± 3.06 19.38 ± 0.57 23.40 ± 1.67*
Creatinine (mg/dL) 0.26 ± 0.02 0.33 ± 0.02* 0.33 ± 0.03* 0.35 ± 0.04*
GOT (U/L) 114.20 ± 22.13 116.40 ± 17.77 153.20 ± 27.40* 168.60 ± 29.53*
GPT (U/L) 31.80 ± 0.84 32.00 ± 3.32 34.40 ± 2.88 36.40 ± 1.52*
*p < 0.05, ZnO NPs versus control
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potential of the particle, but not to the extent that it
changes all the available NH2 groups [33]. In the present
study, we not only utilized fluorescence labeling ZnO
NPs but also used ZnO NPs without fluorescent dyes by
ICP-AES in order to study in vivo biodistribution of





Fig. 7 Protein expression in the kidney tissues using IHC staining and western blot analysis. IHC was used to determine the expression levels of
HIF-1α (a), LC3 (b) and cleaved-caspase-3 (c). d Western blot analysis of protein expression in kidney tissues. The mice were i.p. injected with
ZnO NPs
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Autophagy is a complex catabolic pathway and a highly
dynamic quality control mechanism to recycle cellular
components, eliminate aberrant materials and ultimately
maintain cellular homeostasis. Autophagy can be stimu-
lated by different types of microorganisms, such as bac-
teria, viruses, or parasites. Because NPs are similar in size
to some microorganisms, it is possible that autophagy is
also activated upon internalization of NPs [44, 45], most
likely as a protective response to what is perceived as for-
eign or toxic [46, 47]. Here we prepared ZnO NPs to
examine the induction of autophagy. The formation of
autophagosomes and autophagy-related proteins was sig-
nificantly increased in ZnO NP-treated cells (Fig. 4). TEM
analysis indicated that the autophagosome was formed
from the surrounding proteins and damaged organelles
destined for degradation (Fig. 4e). However, whether au-
tophagy is protective for or cytotoxic to NPs remains con-
troversial. Our previous study found that NPs increased
autophagy due to ROS generation and endoplasmic
reticulum (ER) stress [44]. Other recent studies including
ours, concluded that exposure to NPs is a potential source
of oxidative stress which leads to the induction of ROS,
apoptosis and autophagy [36, 45]. Thus, we investigated
the ROS generated induced by ZnO NPs. Our current
findings showed higher ROS levels in the HEK-293 cells
exposed to ZnO NPs than the controls (Fig. 2a).
Several studies have reported that the subunits of
NADPH oxidase, which are one of the major sources of
ROS, were related to HIF-1α expression in response to
hypoxia in the renal interstitial cells or the A549 cells
[48, 49]. Furthermore, recent evidence shows that NPs
might induce renal fibrosis through a ROS- mediated
HIF-1α signaling pathway [20]. In Fig. 2b, we demon-
strated that HIF-1α expression was increased in cells
treated with ZnO NPs. Additionally, CTGF and PAI-1,
which are directly regulated by HIF and are related to
the pathogenesis of kidney diseases, displayed signifi-
cantly increased levels following ZnO NPs exposure in
HEK-293 cells. In vivo significant increases in kidney-
expressed HIF-1α and CTGF were observed in the ZnO
NP treatment group compared with the control group
(Fig. 7a and d). It is worth mentioning that HIF-1α in-
duces autophagy through BNIP3. BNIP3 stimulates au-
tophagy by preventing the inhibitory binding of Bcl-2 to
Beclin-1, which frees Beclin-1 to participate in autopha-
gosome formation [50]. In our current study, HIF-1α
knockdown by HIF-1α siRNA revealed significantly de-
creased levels of autophagy and increased cytotoxicity
(Fig. 5). Therefore, our results suggest that HIF-1 may
have a protective role in adaptation to the toxicity of
ZnO NPs in kidney cells.
Conclusions
In the present study, the results showed that ZnO NPs
can induce apoptosis and autophagy, accompanied by
ROS and the activation of the HIF-1α signaling pathway,
eventually leading to nephrotoxicity (Fig. 8). Our findings
suggest that ZnO NP-induced autophagy is associated
Fig. 8 ZnO NPs pathways and effects in kidney cells. ZnO NPs induce apoptosis and the HIF-1α signaling pathway through ROS generation, even-
tually leading to nephrotoxicity. Furthermore, ZnO NP-induced autophagy may be mediated by the induction of the HIF-1α signaling pathway. In-
hibition of HIF-1α by HIF-1α siRNA increases the cytotoxicity, indicating a protective role of HIF-1α. In addition, CTGF and PAI-1, which are directly
regulated by HIF and are related to the renal fibrosis, are increased after ZnO NP treatment
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with HIF-1α signaling, which may be an important mech-
anism and protective outcome of kidney diseases caused
by ZnO NPs. In the animal study, the histological analysis
of kidneys from ZnO NP-treated mice showed histopatho-
logical lesions. Furthermore, serum biochemical analysis
showed that BUN, creatinine, GPT and GOT activities,
which indicate possible renal and liver damage, were sig-
nificantly elevated in ZnO NP-treated mice. Therefore, it
is necessary for all researchers or patients who are regu-
larly exposed to ZnO NPs to consider the toxicological
hazards and institute appropriate safety measures.
Additional file
Additional file 1: Table S1. Biochemical tests including BUN, creatinine,
GOT and GPT after i.v. injection of ZnO NPs. Figure S1. Measurements of
the creatinine clearance (CCr) in BALB/c mice during i.p. and i.v. injection
of ZnO NPs. Clearance was calculated based on urine volumes and
serum and urine creatinine concentrations. *p < 0.05 versus 0 mg/kg.
Figure S2. Histopathological analysis of kidneys after i.v. injection of ZnO
NPs (2 mg/kg). Tissue sections were stained with H&E and observed
microscopically. The black arrows indicate tubular dilatation. The black
arrowheads indicate the loss of brush borders and flattened tubular
epithelium. The asterisks indicate the reduction of Bowman’s space and
the increase in cellularity in glomeruli. BS, bowman space; G, glomerulus.
(DOCX 1351 kb)
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